Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation.
- K. Freund, K. P. Doshi, +5 authors A. Stern
- Chemistry, Medicine
- Biochemistry
- 23 August 1994
The physiologic role of several transglutaminases could be more precisely defined with the development of specific inhibitors for these enzymes. In addition, specific plasma transglutaminase (fXIIIa)… Expand
In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.
- S. Vickers, C. Duncan, +7 authors D. Duggan
- Biology, Medicine
- Drug metabolism and disposition: the biological…
- 1 July 1990
Simvastatin (SV), an analog of lovastatin, is the lactone form of 1', 2', 6', 7', 8', 8a'-hexahydro-3,5-dihydroxy-2', 6'-dimethyl-8' (2", 2"-dimethyl-1"-oxobutoxy)-1'-naphthalene-heptanoic acid (SVA)… Expand
High Fatty Acid Content in Rabbit Serum Is Responsible for the Differentiation of Osteoblasts Into Adipocyte‐like Cells
- D. D. Diascro, R. Vogel, +6 authors A. Schmidt
- Biology, Medicine
- Journal of bone and mineral research : the…
- 1 January 1998
Osteoblasts and adipocytes originate from common mesenchymal precursors. With aging, there is a decrease in osteoprogenitor cells that parallels an increase of adipocytes in bone marrow. We observed… Expand
Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure.
- R. Mortishire-Smith, S. Pitzenberger, C. Burke, C. R. Middaugh, V. Garsky, R. G. Johnson
- Chemistry, Medicine
- Biochemistry
- 13 June 1995
Peptides representing the N-terminal domain (Ia) of the cardiac sarcoplasmic reticulum protein phospholamban (residues 1-25 [PLB(1-25)] and a phosphorylated form [pPLB(1-25)]) were synthesized and… Expand
Biotransformation of lovastatin. I. Structure elucidation of in vitro and in vivo metabolites in the rat and mouse.
- K. P. Vyas, P. Kari, +7 authors E. Ulm
- Chemistry, Medicine
- Drug metabolism and disposition: the biological…
- 1 March 1990
Structures of in vitro microsomal and in vivo metabolites of lovastatin, a new cholesterol-lowering drug, were elucidated with the combined application of HPLC, UV, fast atom bombardment-MS, and NMR… Expand
1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido) bicyclo(2.2.1)heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl) piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin…
- P. Williams, P. S. Anderson, +16 authors S. Pitzenberger
- Chemistry
- 5 July 1994
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase.
- N. Liverton, J. W. Butcher, +22 authors S. O'keefe
- Chemistry, Medicine
- Journal of medicinal chemistry
- 17 June 1999
Novel potent and selective diarylimidazole inhibitors of p38 MAP (mitogen-activated protein) kinase are described which have activity in both cell-based assays of tumor necrosis factor-alpha… Expand
Characterization of synthetic parathyroid hormone analogs and of synthetic by-products
- L. Caporale, R. Nutt, +7 authors R. Hirschmann
- Chemistry
- 1989
Characterization of a Solid State Reaction Product from a Lyophilized Formulation of a Cyclic Heptapeptide. A Novel Example of an Excipient-Induced Oxidation
- David C. Dubost, M. J. Kaufman, J. A. Zimmerman, M. Bogusky, A. B. Coddington, S. Pitzenberger
- Chemistry, Medicine
- Pharmaceutical Research
- 10 November 1996
AbstractPurpose. To elucidate the structure of a degradation product arising from a lyophilized formulation of a cyclic heptapeptide, and to provide a mechanism to account for its formation.
Methods.… Expand
Identification of fatty acid methyl ester as naturally occurring transcriptional regulators of the members of the peroxisome proliferator-activated receptor family
- A. Schmidt, R. Vogel, +4 authors G. Rodan
- Chemistry, Medicine
- Lipids
- 1 November 1996
The nuclear hormone receptors NUC-1 (PPARξ) and PPARα are members of the peroxisome proliferator-activated receptor (PPAR) family. The members of this receptor family are activated by agents that… Expand